Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis

Abstract

The increased BTLA and HVEM levels correlate with the development and poor prognosis of gastric cancer. HVEM is an important prognostic indicator, and BTLA/HVEM pathway is considered to be a promising candidate for immunotherapy of gastric cancer.